Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Cell MedX Corp. (CMXC)

Total paid for Promotions this month: $52,000
E-mails this Month: 31
Estimated Volume Generated: $65,505
Research Report on CMXC: Click to see
* The information presented is based on information for Apr , 2015
  Click Here To Unsubscribe   ISP Free Members,     A new era is dawning in the management of diabetes.   This exciting new company aims to release its first lineup of commercial products in early 2016, starting with its patent-pending flagship product, known as e-balance, which works to improve the effectiveness of the clients' existing diabetes medication regimes.   Biotech ...read more
Promoter: InsiderStockProvider.com Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe   Members,     A new era is dawning in the management of diabetes.   This exciting new company aims to release its first lineup of commercial products in early 2016, starting with its patent-pending flagship product, known as e-balance, which works to improve the effectiveness of the clients' existing diabetes medication regimes.   Biotech ...read more
Promoter: ResearchOTC.com Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe   Members,     A new era is dawning in the management of diabetes.   This exciting new company aims to release its first lineup of commercial products in early 2016, starting with its patent-pending flagship product, known as e-balance, which works to improve the effectiveness of the clients' existing diabetes medication regimes.   Biotech companies ...read more
Promoter: MomentumOTC Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe   Members,     A new era is dawning in the management of diabetes.   This exciting new company aims to release its first lineup of commercial products in early 2016, starting with its patent-pending flagship product, known as e-balance, which works to improve the effectiveness of the clients' existing diabetes medication regimes.   Biotech ...read more
Promoter: Stock Rockand Roll Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe   Members,   Let's not waste any time.   We're looking to extend our win streak to 6 in a row tomorrow with an exciting new biotech alert that has developed a 'shocking' new medical treatment for diabetes!   Immediately turn your attention to CMXC (Cell MedX Corp.).   The company is focused on the discovery, development and commercialization ...read more
Promoter: MomentumOTC Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe       Members,   Let's not waste any time.   We're looking to extend our win streak to 6 in a row tomorrow with an exciting new biotech alert that has developed a 'shocking' new medical treatment for diabetes!   Immediately turn your attention to CMXC (Cell MedX Corp.).   The company is focused on the discovery, development and commercialization of therapeutic ...read more
Promoter: PennyStockLocks.com Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe   ISP Free Members,     Let's not waste any time.   We're looking to extend our win streak to 6 in a row tomorrow with an exciting new biotech alert that has developed a 'shocking' new medical treatment for diabetes!   Immediately turn your attention to CMXC (Cell MedX Corp.).   The company is focused on the discovery, development and commercialization ...read more
Promoter: InsiderStockProvider.com Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  Click Here To Unsubscribe   Members,     Let's not waste any time.   We're looking to extend our win streak to 6 in a row tomorrow with an exciting new biotech alert that has developed a 'shocking' new medical treatment for diabetes!   Immediately turn your attention to CMXC (Cell MedX Corp.).   The company is focused on the discovery, development and commercialization ...read more
Promoter: Stock Rockand Roll Paying Party: 007 Stock Chat, LLC.
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $11,500 UNKNOWN
Max Profit: 6.90 % Gain at close: -2.43 %
  I get particularly excited about biotech companies, but I am absolutely overjoyed when they are actually conducting clinical trials. You can probably guess why; biotech companies thrive on clinical trials because the sooner they get them done, the sooner they can get FDA approval and make millions, sometimes in even billions of dollars in revenues. The story is no different with my latest pick. CMXC comes to the market with a unique e-balance ...read more
Promoter: StockCabin.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $9,000 24,000
Max Profit: 6.90 % Gain at close: -2.43 %
hello, i am happy to have you as a member of the Equity community, yet  if at any time you feel you would no longer like to receive my emails, please use the button to the right to un-list. Thanks so much :)   Hi and good morning,   I hope you’ve ha d a chance to do your research on today’s new play CMXC as it could have a big day ahead:   Today’s new play is Cell MedX Corp. (CMXC)   CMXC ...read more
Promoter: OTCEquity Paying Party: Taramara Investments Inc
Stocks covered: Compensation: Avg $ Volume for Period:
CMXC $3,500 2,115
Max Profit: 0.13 % Gain at close: -9.45 %
First  >> Last